• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Oncology

Endocrine therapy and breast-conserving surgical management without follow-up radiotherapy is safe in low-risk, luminal A subtype breast cancer

byKassandra McFarlaneandSze Wah Samuel Chan
August 21, 2023
in Chronic Disease, Oncology
Reading Time: 2 mins read
Radiation therapy collage: an older woman in a calm portrait beside the curved arm of a treatment machine and a mesh mask
Share on FacebookShare on TwitterShare on LinkedIn

1. 5-year recurrence incidence was 2.5% at follow-up.

2. Overall survival at 5 years without radiotherapy was 97.2%, with a disease-free survival rate of 89.9%.

Evidence Rating Level: 1 (Excellent)

Study Rundown: After breast-conserving surgical management of breast cancer, radiotherapy is often provided to help prevent recurrence, but not without inconvenience, increased risk of side effects, and considerable cost financially. Low-risk subtypes of breast cancer include the luminal A-subtype, described as having negative human epidermal growth factor receptor 2, estrogen receptor positivity of ≥1%, progesterone receptor positivity of >20%, and Ki67 index of 13.25% or less. The Ki67 index can be used to distinguish between low- and high-risk subtypes. This study prospectively examined the outcomes of recurrence in selectively chosen, low-risk female patients age 55+ years with subtype A breast cancers, whose treatment omitted radiotherapy, and who were provided only breast-conserving surgery after endocrine therapy. The primary outcome of this study was the recurrence of invasive or in situ cancer of the ipsilateral breast. Secondary outcomes included disease-free survival and overall survival. Median follow-up time was 5 years after treatment, at which point a local recurrence was noted in 10 patients, all of which were invasive. A total of 8 contralateral recurrences were observed in 5 years. There were 47 disease events recorded during follow-up, for a 5-year disease-free survival of 89.9%. Overall survival at 5 years was 97.2%. Limitations to this study include that the study population age was limited to age 55 or older. The results of this study should be applied cautiously to populations younger than this. Also, as the study population excluded patients with lobular cancer, multifocal tumours, extensive intraductal involvement or lymphovascular invasion, results from this study may not apply to these groups. Overall, the results from this study support that the omission of radiotherapy after conservative breast-sparing surgery and endocrine therapy for low-risk, luminal A subtype breast cancer is an effective management approach.

Click to read the study in the NEJM (New England Journal of Medicine)

Relevant Reading: Radiation therapy after breast-conserving surgery in women 70 years of age

RELATED REPORTS

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

and older: how wisely do we choose?

FDA approvedFor breast cancer: Etcamah (camizestrant), Sep 4, 2026→

In-Depth [prospective cohort]: This study was a prospective cohort study that followed 500 adult female patients from 26 centres in Canada who were at least 55 years old and who received only breast-conserving surgical treatment and adjuvant endocrine therapy for their grade 1 or 2, T1N0, luminal A-subtype breast cancer. With a median follow-up time of 5 years, there were only 10 local recurrences noted. Cumulative incidence at 5 years post-treatment was found to be 2.3% (90% confidence interval [CI], 1.3 to 3.8; 95% CI, 1.2 – 4.1). The 5-year recurrence incidence was calculated to be 2.5% (90% CI, 1.5 – 4.0). The 5-year cumulative incidence of contralateral breast cancers was 1.9% (90% CI, 1.1 – 3.2). The disease-free survival at 5 years was 89.9% (90% CI, 87.5 – 92.2%). At 5 years, the overall survival was 97.2% (90% CI, 95.9 – 98.4%). These findings support that standard treatment omitting radiotherapy in a low-risk luminal A phenotype results in a very low incidence of local recurrence at 5 years.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancerluminal Aradiotherapy
Previous Post

Short sleep duration may be associated with the presence of dental caries

Next Post

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

RelatedReports

A middle-aged woman looks thoughtfully at an abstract representation of cells and a statin pill, symbolizing breast cancer and medication usage.
Oncology

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

October 5, 2026
Sleep disorders collage: an engraved pillow and rumpled sheet with a dark sleep mask, a paper crescent moon and a teal ribbon
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Breast cancer care collage: a calm woman in a turtleneck sweater beside a folded paper crane and a small white pill bottle
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Sleep disorders collage: an engraved pillow and rumpled sheet with a dark sleep mask, a paper crescent moon and a teal ribbon
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Next Post
Addition of bevacizumab fails to benefit overall survival in newly diagnosed glioblastoma [RTOG 0825 trial]

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Sleep extension is associated with improvements in athletic performance

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: FIFA Women’s World Cup, National Immunization Awareness Month, Back-to-School, Overdose Awareness, Maintenance of Certification Frustrations, and Wegovy for Weight Loss and the Heart

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Percutaneous nephrolithotomy and flexible ureteroscopy may have similar outcomes in pediatric nephrolithiasis
  • Cannabis use, including smoked or edible, linked to higher stroke risk
  • Ivonescimab plus chemotherapy produced major and complete pathological responses in resectable NSCLC in a phase II study
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.